Hutchmed (HCM) announced that it has completed enrollment of its a Phase II trial of fanregratinib for intrahepatic cholangiocarcinoma patients ...

"Taleo is incremental to Fusion." Oracle's next-generation Fusion financial, HCM and CRM applications are designed to eventually succeed its Oracle E-Business Suite and acquired applications such ...